# Impact of Uterine Immune Profiling and Personalized Treatments in Patients Receiving a Single Blastocyst: a Matched Controlled Study

> **NCT06503952** · — · NOT_YET_RECRUITING · sponsor: **Matricelab Innove** · enrollment: 340 (estimated)

## Conditions studied

- Infertility
- Success Rate of Assisted Reproductive Therapy
- Single Embryo Transfer
- Pregnancy Outcomes
- Immunological Tolerance
- Immune System

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06503952
- **Lead sponsor:** Matricelab Innove
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-15
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06503952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06503952, "Impact of Uterine Immune Profiling and Personalized Treatments in Patients Receiving a Single Blastocyst: a Matched Controlled Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06503952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*